How Long Does Suboxone Stay in Your System?

Whether you're starting medication-assisted treatment, transitioning off it, or preparing for a drug test, understanding how Suboxone behaves in your body helps you know what to expect. Suboxone is different from most opioids in an important way: it's built to stay in your system longer, on purpose.

The short answer: buprenorphine, the active ingredient in Suboxone, has a long half-life of roughly 24 to 42 hours — which is why it can be detected on a standard urine test for 3 to 6 days after the last dose, longer with regular, extended use. Suboxone does not trigger a standard opiate drug screen; it requires a test specific to buprenorphine.

What Is Suboxone, and Why Its Duration Is Different by Design

Suboxone combines buprenorphine, a partial opioid agonist, with naloxone, an opioid blocker added to discourage misuse by injection. As part of medication-assisted treatment (MAT), buprenorphine is intentionally long-acting — it's designed to occupy opioid receptors steadily over a full day or more, smoothing out the sharp peaks and withdrawal dips that make short-acting opioids so difficult to quit. That deliberate design is exactly why it stays detectable longer than most opioids people are familiar with.

Half-Life and How Buprenorphine Is Cleared

Buprenorphine's half-life of 24 to 42 hours is dramatically longer than short-acting opioids like heroin or oxycodone, which typically clear in a matter of hours. Naloxone, the second component in Suboxone, has a much shorter half-life of roughly 2 to 12 hours and isn't the focus of most testing, since it's included primarily as a misuse deterrent rather than for its own therapeutic effect.

Detection Windows by Test Type

• Urine: 3 to 6 days typically, extending to 7 to 10 days or longer with chronic, high-dose use.
• Blood: roughly 1 to 2 days.
• Saliva: approximately 1 to 3 days.

What Affects How Long Suboxone Stays Detectable

Dose and length of treatment matter most — someone on a stable, long-term maintenance dose will generally show a longer detection window than someone newer to treatment. Individual liver function and overall metabolism also play a meaningful role, since buprenorphine is metabolized hepatically (unlike gabapentin, which relies on the kidneys).

Does Suboxone Show Up on a Standard Drug Test?

No — this is one of the most common points of confusion for people starting MAT. Standard opiate immunoassays are calibrated to detect morphine-derivative opioids and reliably miss buprenorphine entirely. A dedicated buprenorphine panel is required to detect it, which is worth knowing both for patients navigating employment drug screens and for anyone trying to make sense of a "clean" opiate result that doesn't tell the whole story.

What This Means If You're Starting or Stopping Suboxone

If you're beginning treatment, a positive buprenorphine test is the expected, intended result of prescribed MAT — not a red flag. If you're tapering off under medical supervision, the same long half-life that makes Suboxone effective also means withdrawal, when it happens, tends to be more gradual than with short-acting opioids. Neither of these is something to navigate without your care team; Scioto's outpatient program is built specifically around supporting people through both the start and the eventual, physician-guided end of MAT.

Frequently Asked Questions

Will Suboxone show up on a regular drug test?

Not on a standard opiate panel — detecting buprenorphine requires a test specifically designed to screen for it.

How long after stopping Suboxone will it show up on a urine test?

Generally 3 to 6 days, extending to a week or more with long-term use.

Does Suboxone stay in your system longer than other opioids?

Yes — its 24-to-42-hour half-life is much longer than short-acting opioids, which is also why its withdrawal is more gradual.

What affects how long Suboxone stays detectable?

Dose, length of treatment, individual liver function, and metabolism.

Is a positive buprenorphine test a problem in a supervised treatment program?

No — patients on prescribed MAT are expected to test positive for it; that's expected, not concerning.

Medically informational content — not a substitute for professional medical advice. Source: SAMHSA — Buprenorphine.